Mylan, Hospira, and Celltrion join amici supporting Apotex before Fed. Cir.

Amgen v. Apotex (pegfilgrastim)  •  Biosimilar News  •  BPCIA and Related U.S. Statutes  •  U.S. Biosimilar Litigation News

Yesterday Mylan, and Hospira and Celltrion (jointly) filed amicus briefs in support of Apotex’s appeal to the Federal Circuit in Amgen v. Apotex.  They joined the Biosimilars Council, which filed its amicus brief Wednesday.  Further analysis to come.

Download PDF

Comments are closed.